TherapeuticsMD, Inc. (TXMD)
Q2 2019 Earnings Conference Call
August 06, 2019 4:30 PM ET
Company Participants
Nichol Ochsner - Vice President of Investor Relations
Robert Finizio - Chief Executive Officer
Daniel Cartwright - Chief Financial Officer
Dawn Halkuff - Chief Commercial Officer
Conference Call Participants
Louise Chen - Cantor Fitzgerald
Annabel Samimy - Stifel
Jay Olson - Oppenheimer
Presentation
Operator
Good afternoon, ladies and gentlemen. Thank you for joining us for the TherapeuticsMD Second Quarter 2019 Financial Results Conference Call. Following prepared remarks from the company, we will open the call for questions.
I would